Triamterene and Hydrochlorothiazide
- Product NDC
- 53002-2252
- 11-digit product format
- 530022252
- Labeler code
- 53002
- Product ID
- 53002-2252_efc365bd-d5d0-4589-a46b-02508a93fed8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Triamterene and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- RPK Pharmaceuticals, Inc.
- Application
- ANDA071251
- Marketing category
- ANDA
- Marketing start
- 2009-09-21
- Marketing end
- 0000-00-00
- Substance
- TRIAMTERENE; HYDROCHLOROTHIAZIDE
- Active strength
- 38 mg/1; mg/1
- Pharmacologic classes
- Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS],Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 53002-2252-0 | Triamterene and Hydrochlorothiazide | 100 in 1 BOTTLE | TABLET | 100 | | 4 |
| 53002-2252-3 | Triamterene and Hydrochlorothiazide | 30 in 1 BOTTLE | TABLET | 30 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 53002-2252 | TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [RPK PHARMACEUTICALS, INC.] | 4 | Legacy NDC, 2 package rows | 20230609_90277796-e95a-4e0e-b1d4-784b920cc7bb.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 53002-2252-0 | 53002225200 | 100 TABLET in 1 BOTTLE (53002-2252-0) | 100 tablet | 2021-05-01 | 0000-00-00 | No | No | Current |
| 53002-2252-3 | 53002225203 | 30 TABLET in 1 BOTTLE (53002-2252-3) | 30 tablet | 2021-05-01 | 0000-00-00 | No | No | Current |